Alzheimer's experts call for changes in FDA drug approval standards

(Amplify Public Affairs) Leading Alzheimer's disease researchers and a prominent patient advocate today published an analysis, 'Single Endpoint for New Drug Approvals for Alzheimer's Disease,' urging the Food and Drug Administration (FDA) to clarify and modernize its current approach for approving new treatments for Alzheimer's disease.

from EurekAlert! - Social and Behavioral Science http://ift.tt/2q6fW8q